These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21927961)

  • 1. Preparation and characterization of a lovastatin-loaded protein-free nanostructured lipid carrier resembling high-density lipoprotein and evaluation of its targeting to foam cells.
    Gu X; Zhang W; Liu J; Shaw JP; Shen Y; Xu Y; Lu H; Wu Z
    AAPS PharmSciTech; 2011 Dec; 12(4):1200-8. PubMed ID: 21927961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanostructured lipid carriers constituted from high-density lipoprotein components for delivery of a lipophilic cardiovascular drug.
    Zhang WL; Gu X; Bai H; Yang RH; Dong CD; Liu JP
    Int J Pharm; 2010 May; 391(1-2):313-21. PubMed ID: 20214958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Fatty Acid Modification on Uptake of Lovastatin-Loaded Reconstituted High Density Lipoprotein by Foam Cells.
    Yang Y; Wang J; He H; Zhang W; Zhang Y; Liu J
    Pharm Res; 2018 May; 35(7):134. PubMed ID: 29736804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arachidonic acid-modified lovastatin discoidal reconstituted high density lipoprotein markedly decreases the drug leakage during the remodeling behaviors induced by lecithin cholesterol acyltransferase.
    He H; Liu L; Bai H; Wang J; Zhang Y; Zhang W; Zhang M; Wu Z; Liu J
    Pharm Res; 2014 Jul; 31(7):1689-709. PubMed ID: 24449440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of oral bioavailability of lovastatin by using nanostructured lipid carriers.
    Zhou J; Zhou D
    Drug Des Devel Ther; 2015; 9():5269-75. PubMed ID: 26425076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying.
    Zhang X; Pan W; Gan L; Zhu C; Gan Y; Nie S
    Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1645-50. PubMed ID: 19043233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
    Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
    Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tanshinone IIA-loaded reconstituted high density lipoproteins: Atherosclerotic plaque targeting mechanism in a foam cell model and pharmacokinetics in rabbits.
    Zhang W; Li J; Liu J; Wu Z; Xu Y; Wang J
    Pharmazie; 2012 Apr; 67(4):324-30. PubMed ID: 22570939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology.
    Zhang W; Li X; Ye T; Chen F; Sun X; Kong J; Yang X; Pan W; Li S
    Int J Pharm; 2013 Sep; 454(1):354-66. PubMed ID: 23876384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting.
    Meng F; Asghar S; Xu Y; Wang J; Jin X; Wang Z; Wang J; Ping Q; Zhou J; Xiao Y
    Int J Pharm; 2016 Jun; 506(1-2):46-56. PubMed ID: 27094357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization.
    Shete H; Patravale V
    Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis.
    Pinheiro M; Ribeiro R; Vieira A; Andrade F; Reis S
    Drug Des Devel Ther; 2016; 10():2467-75. PubMed ID: 27536067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation and characterization of oxaliplatin-loaded nanostructured lipid carriers].
    Zhou H; Qiu LP; Yan XX; Li L; Li X; Wang L; Liu M; Wang DK
    Yao Xue Xue Bao; 2010 Sep; 45(9):1177-82. PubMed ID: 21351576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications.
    Araújo J; Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
    Int J Pharm; 2010 Jun; 393(1-2):167-75. PubMed ID: 20362042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro formation of HDL-2 from HDL-3 and triacylglycerol-rich lipoproteins by the action of lecithin:cholesterol acyltransferase and cholesterol ester transfer protein.
    Zechner R; Dieplinger H; Steyrer E; Groener J; Calvert D; Kostner GM
    Biochim Biophys Acta; 1987 Mar; 918(1):27-35. PubMed ID: 3828365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers.
    Thatipamula R; Palem C; Gannu R; Mudragada S; Yamsani M
    Daru; 2011; 19(1):23-32. PubMed ID: 22615636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical characteristics, cytotoxicity, and antioxidant activity of three lipid nanoparticulate formulations of alpha-lipoic acid.
    Ruktanonchai U; Bejrapha P; Sakulkhu U; Opanasopit P; Bunyapraphatsara N; Junyaprasert V; Puttipipatkhachorn S
    AAPS PharmSciTech; 2009; 10(1):227-34. PubMed ID: 19280350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
    Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW
    Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photo-responsive and NGR-mediated multifunctional nanostructured lipid carrier for tumor-specific therapy.
    Yang Y; Xie X; Yang Y; Zhang H; Mei X
    J Pharm Sci; 2015 Apr; 104(4):1328-39. PubMed ID: 25630979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.